Skip to main content
NCBI home page
The EMBO Journal logoLink to The EMBO Journal
. 1999 Feb 15;18(4):1038–1048. doi: 10.1093/emboj/18.4.1038

Structural basis for the specificity of the initiation of HIV-1 reverse transcription.

C Isel 1, E Westhof 1, C Massire 1, S F Le Grice 1, B Ehresmann 1, C Ehresmann 1, R Marquet 1
PMCID: PMC1171195  PMID: 10022845

Abstract

Initiation of human immunodeficiency virus type 1 (HIV-1) reverse transcription requires specific recognition of the viral genome, tRNA3Lys, which acts as primer, and reverse transcriptase (RT). The specificity of this ternary complex is mediated by intricate interactions between HIV-1 RNA and tRNA3Lys, but remains poorly understood at the three-dimensional level. We used chemical probing to gain insight into the three-dimensional structure of the viral RNA-tRNA3Lys complex, and enzymatic footprinting to delineate regions interacting with RT. These and previous experimental data were used to derive a three-dimensional model of the initiation complex. The viral RNA and tRNA3Lys form a compact structure in which the two RNAs fold into distinct structural domains. The extended interactions between these molecules are not directly recognized by RT. Rather, they favor RT binding by preventing steric clashes between the nucleic acids and the polymerase and inducing a viral RNA-tRNA3Lys conformation which fits perfectly into the nucleic acid binding cleft of RT. Recognition of the 3' end of tRNA3Lys and of the first template nucleotides by RT is favored by a kink in the template strand promoted by the short junctions present in the previously established secondary structure.

Full Text

The Full Text of this article is available as a PDF (685.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aiyar A., Cobrinik D., Ge Z., Kung H. J., Leis J. Interaction between retroviral U5 RNA and the T psi C loop of the tRNA(Trp) primer is required for efficient initiation of reverse transcription. J Virol. 1992 Apr;66(4):2464–2472. doi: 10.1128/jvi.66.4.2464-2472.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aiyar A., Ge Z., Leis J. A specific orientation of RNA secondary structures is required for initiation of reverse transcription. J Virol. 1994 Feb;68(2):611–618. doi: 10.1128/jvi.68.2.611-618.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arts E. J., Le Grice S. F. Interaction of retroviral reverse transcriptase with template-primer duplexes during replication. Prog Nucleic Acid Res Mol Biol. 1998;58:339–393. doi: 10.1016/s0079-6603(08)60041-0. [DOI] [PubMed] [Google Scholar]
  4. Arts E. J., Miller J. T., Ehresmann B., Le Grice S. F. Mutating a region of HIV-1 reverse transcriptase implicated in tRNA(Lys-3) binding and the consequences for (-)-strand DNA synthesis. J Biol Chem. 1998 Jun 5;273(23):14523–14532. doi: 10.1074/jbc.273.23.14523. [DOI] [PubMed] [Google Scholar]
  5. Arts E. J., Stetor S. R., Li X., Rausch J. W., Howard K. J., Ehresmann B., North T. W., Wöhrl B. M., Goody R. S., Wainberg M. A. Initiation of (-) strand DNA synthesis from tRNA(3Lys) on lentiviral RNAs: implications of specific HIV-1 RNA-tRNA(3Lys) interactions inhibiting primer utilization by retroviral reverse transcriptases. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10063–10068. doi: 10.1073/pnas.93.19.10063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baltimore D. RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature. 1970 Jun 27;226(5252):1209–1211. doi: 10.1038/2261209a0. [DOI] [PubMed] [Google Scholar]
  7. Baudin F., Marquet R., Isel C., Darlix J. L., Ehresmann B., Ehresmann C. Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains. J Mol Biol. 1993 Jan 20;229(2):382–397. doi: 10.1006/jmbi.1993.1041. [DOI] [PubMed] [Google Scholar]
  8. Cate J. H., Gooding A. R., Podell E., Zhou K., Golden B. L., Kundrot C. E., Cech T. R., Doudna J. A. Crystal structure of a group I ribozyme domain: principles of RNA packing. Science. 1996 Sep 20;273(5282):1678–1685. doi: 10.1126/science.273.5282.1678. [DOI] [PubMed] [Google Scholar]
  9. Celander D. W., Cech T. R. Visualizing the higher order folding of a catalytic RNA molecule. Science. 1991 Jan 25;251(4992):401–407. doi: 10.1126/science.1989074. [DOI] [PubMed] [Google Scholar]
  10. Cobrinik D., Soskey L., Leis J. A retroviral RNA secondary structure required for efficient initiation of reverse transcription. J Virol. 1988 Oct;62(10):3622–3630. doi: 10.1128/jvi.62.10.3622-3630.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Colicelli J., Goff S. P. Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J Virol. 1986 Jan;57(1):37–45. doi: 10.1128/jvi.57.1.37-45.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cordell B., Swanstrom R., Goodman H. M., Bishop J. M. tRNATrp as primer for RNA-directed DNA polymerase: structural determinants of function. J Biol Chem. 1979 Mar 25;254(6):1866–1874. [PubMed] [Google Scholar]
  13. Das A. T., Klaver B., Berkhout B. Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys). J Virol. 1995 May;69(5):3090–3097. doi: 10.1128/jvi.69.5.3090-3097.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ding J., Hughes S. H., Arnold E. Protein-nucleic acid interactions and DNA conformation in a complex of human immunodeficiency virus type 1 reverse transcriptase with a double-stranded DNA template-primer. Biopolymers. 1997;44(2):125–138. doi: 10.1002/(SICI)1097-0282(1997)44:2<125::AID-BIP2>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  15. Doublié S., Tabor S., Long A. M., Richardson C. C., Ellenberger T. Crystal structure of a bacteriophage T7 DNA replication complex at 2.2 A resolution. Nature. 1998 Jan 15;391(6664):251–258. doi: 10.1038/34593. [DOI] [PubMed] [Google Scholar]
  16. Elgavish T., VanLoock M. S., Harvey S. C. Exploring three-dimensional structures of the HIV-1 RNA/tRNALys3 initiation complex. J Mol Biol. 1999 Jan 15;285(2):449–453. doi: 10.1006/jmbi.1998.2310. [DOI] [PubMed] [Google Scholar]
  17. Esnouf R., Ren J., Ross C., Jones Y., Stammers D., Stuart D. Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors. Nat Struct Biol. 1995 Apr;2(4):303–308. doi: 10.1038/nsb0495-303. [DOI] [PubMed] [Google Scholar]
  18. Fossé P., Mougel M., Keith G., Westhof E., Ehresmann B., Ehresmann C. Modified nucleotides of tRNAPro restrict interactions in the binary primer/template complex of M-MuLV. J Mol Biol. 1998 Feb 6;275(5):731–746. doi: 10.1006/jmbi.1997.1487. [DOI] [PubMed] [Google Scholar]
  19. Friant S., Heyman T., Wilhelm M. L., Wilhelm F. X. Extended interactions between the primer tRNAi(Met) and genomic RNA of the yeast Ty1 retrotransposon. Nucleic Acids Res. 1996 Feb 1;24(3):441–449. doi: 10.1093/nar/24.3.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gilboa E., Mitra S. W., Goff S., Baltimore D. A detailed model of reverse transcription and tests of crucial aspects. Cell. 1979 Sep;18(1):93–100. doi: 10.1016/0092-8674(79)90357-x. [DOI] [PubMed] [Google Scholar]
  21. Götte M., Fackler S., Hermann T., Perola E., Cellai L., Gross H. J., Le Grice S. F., Heumann H. HIV-1 reverse transcriptase-associated RNase H cleaves RNA/RNA in arrested complexes: implications for the mechanism by which RNase H discriminates between RNA/RNA and RNA/DNA. EMBO J. 1995 Feb 15;14(4):833–841. doi: 10.1002/j.1460-2075.1995.tb07061.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Huang H., Chopra R., Verdine G. L., Harrison S. C. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science. 1998 Nov 27;282(5394):1669–1675. doi: 10.1126/science.282.5394.1669. [DOI] [PubMed] [Google Scholar]
  23. Huang Y., Shalom A., Li Z., Wang J., Mak J., Wainberg M. A., Kleiman L. Effects of modifying the tRNA(3Lys) anticodon on the initiation of human immunodeficiency virus type 1 reverse transcription. J Virol. 1996 Jul;70(7):4700–4706. doi: 10.1128/jvi.70.7.4700-4706.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Isel C., Ehresmann C., Keith G., Ehresmann B., Marquet R. Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(3Lys) (template/primer). J Mol Biol. 1995 Mar 24;247(2):236–250. doi: 10.1006/jmbi.1994.0136. [DOI] [PubMed] [Google Scholar]
  25. Isel C., Keith G., Ehresmann B., Ehresmann C., Marquet R. Mutational analysis of the tRNA3Lys/HIV-1 RNA (primer/template) complex. Nucleic Acids Res. 1998 Mar 1;26(5):1198–1204. doi: 10.1093/nar/26.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Isel C., Lanchy J. M., Le Grice S. F., Ehresmann C., Ehresmann B., Marquet R. Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNA3Lys. EMBO J. 1996 Feb 15;15(4):917–924. [PMC free article] [PubMed] [Google Scholar]
  27. Isel C., Marquet R., Keith G., Ehresmann C., Ehresmann B. Modified nucleotides of tRNA(3Lys) modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription. J Biol Chem. 1993 Dec 5;268(34):25269–25272. [PubMed] [Google Scholar]
  28. Jacobo-Molina A., Ding J., Nanni R. G., Clark A. D., Jr, Lu X., Tantillo C., Williams R. L., Kamer G., Ferris A. L., Clark P. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6320–6324. doi: 10.1073/pnas.90.13.6320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Jäger J., Smerdon S. J., Wang J., Boisvert D. C., Steitz T. A. Comparison of three different crystal forms shows HIV-1 reverse transcriptase displays an internal swivel motion. Structure. 1994 Sep 15;2(9):869–876. doi: 10.1016/s0969-2126(94)00087-5. [DOI] [PubMed] [Google Scholar]
  30. Kang S. M., Zhang Z., Morrow C. D. Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met). J Virol. 1997 Jan;71(1):207–217. doi: 10.1128/jvi.71.1.207-217.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kiefer J. R., Mao C., Braman J. C., Beese L. S. Visualizing DNA replication in a catalytically active Bacillus DNA polymerase crystal. Nature. 1998 Jan 15;391(6664):304–307. doi: 10.1038/34693. [DOI] [PubMed] [Google Scholar]
  32. Kohlstaedt L. A., Wang J., Friedman J. M., Rice P. A., Steitz T. A. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science. 1992 Jun 26;256(5065):1783–1790. doi: 10.1126/science.1377403. [DOI] [PubMed] [Google Scholar]
  33. Lanchy J. M., Ehresmann C., Le Grice S. F., Ehresmann B., Marquet R. Binding and kinetic properties of HIV-1 reverse transcriptase markedly differ during initiation and elongation of reverse transcription. EMBO J. 1996 Dec 16;15(24):7178–7187. [PMC free article] [PubMed] [Google Scholar]
  34. Latham J. A., Cech T. R. Defining the inside and outside of a catalytic RNA molecule. Science. 1989 Jul 21;245(4915):276–282. doi: 10.1126/science.2501870. [DOI] [PubMed] [Google Scholar]
  35. Le Grice S. F., Grüninger-Leitch F. Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. Eur J Biochem. 1990 Jan 26;187(2):307–314. doi: 10.1111/j.1432-1033.1990.tb15306.x. [DOI] [PubMed] [Google Scholar]
  36. Li X., Mak J., Arts E. J., Gu Z., Kleiman L., Wainberg M. A., Parniak M. A. Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication. J Virol. 1994 Oct;68(10):6198–6206. doi: 10.1128/jvi.68.10.6198-6206.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Li Y., Zhang Z., Wakefield J. K., Kang S. M., Morrow C. D. Nucleotide substitutions within U5 are critical for efficient reverse transcription of human immunodeficiency virus type 1 with a primer binding site complementary to tRNA(His). J Virol. 1997 Sep;71(9):6315–6322. doi: 10.1128/jvi.71.9.6315-6322.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Liang C., Li X., Rong L., Inouye P., Quan Y., Kleiman L., Wainberg M. A. The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity. J Virol. 1997 Aug;71(8):5750–5757. doi: 10.1128/jvi.71.8.5750-5757.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Lund A. H., Duch M., Lovmand J., Jørgensen P., Pedersen F. S. Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer. J Virol. 1997 Feb;71(2):1191–1195. doi: 10.1128/jvi.71.2.1191-1195.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Lund A. H., Duch M., Lovmand J., Jørgensen P., Pedersen F. S. Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication. J Virol. 1993 Dec;67(12):7125–7130. doi: 10.1128/jvi.67.12.7125-7130.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Mak J., Kleiman L. Primer tRNAs for reverse transcription. J Virol. 1997 Nov;71(11):8087–8095. doi: 10.1128/jvi.71.11.8087-8095.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Marquet R., Isel C., Ehresmann C., Ehresmann B. tRNAs as primer of reverse transcriptases. Biochimie. 1995;77(1-2):113–124. doi: 10.1016/0300-9084(96)88114-4. [DOI] [PubMed] [Google Scholar]
  43. Massire C., Gaspin C., Westhof E. DRAWNA: a program for drawing schematic views of nucleic acids. J Mol Graph. 1994 Sep;12(3):201-6, 196. doi: 10.1016/0263-7855(94)80088-x. [DOI] [PubMed] [Google Scholar]
  44. Metzger W., Hermann T., Schatz O., Le Grice S. F., Heumann H. Hydroxyl radical footprint analysis of human immunodeficiency virus reverse transcriptase-template.primer complexes. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):5909–5913. doi: 10.1073/pnas.90.13.5909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Mishima Y., Steitz J. A. Site-specific crosslinking of 4-thiouridine-modified human tRNA(3Lys) to reverse transcriptase from human immunodeficiency virus type I. EMBO J. 1995 Jun 1;14(11):2679–2687. doi: 10.1002/j.1460-2075.1995.tb07266.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Murphy F. L., Cech T. R. GAAA tetraloop and conserved bulge stabilize tertiary structure of a group I intron domain. J Mol Biol. 1994 Feb 11;236(1):49–63. doi: 10.1006/jmbi.1994.1117. [DOI] [PubMed] [Google Scholar]
  47. Oude Essink B. B., Das A. T., Berkhout B. HIV-1 reverse transcriptase discriminates against non-self tRNA primers. J Mol Biol. 1996 Nov 29;264(2):243–254. doi: 10.1006/jmbi.1996.0638. [DOI] [PubMed] [Google Scholar]
  48. Paillart J. C., Marquet R., Skripkin E., Ehresmann B., Ehresmann C. Mutational analysis of the bipartite dimer linkage structure of human immunodeficiency virus type 1 genomic RNA. J Biol Chem. 1994 Nov 4;269(44):27486–27493. [PubMed] [Google Scholar]
  49. Peattie D. A., Gilbert W. Chemical probes for higher-order structure in RNA. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4679–4682. doi: 10.1073/pnas.77.8.4679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Richmond T. J. Solvent accessible surface area and excluded volume in proteins. Analytical equations for overlapping spheres and implications for the hydrophobic effect. J Mol Biol. 1984 Sep 5;178(1):63–89. doi: 10.1016/0022-2836(84)90231-6. [DOI] [PubMed] [Google Scholar]
  51. Sawaya M. R., Prasad R., Wilson S. H., Kraut J., Pelletier H. Crystal structures of human DNA polymerase beta complexed with gapped and nicked DNA: evidence for an induced fit mechanism. Biochemistry. 1997 Sep 16;36(37):11205–11215. doi: 10.1021/bi9703812. [DOI] [PubMed] [Google Scholar]
  52. Serganov A. A., Masquida B., Westhof E., Cachia C., Portier C., Garber M., Ehresmann B., Ehresmann C. The 16S rRNA binding site of Thermus thermophilus ribosomal protein S15: comparison with Escherichia coli S15, minimum site and structure. RNA. 1996 Nov;2(11):1124–1138. [PMC free article] [PubMed] [Google Scholar]
  53. Skripkin E., Isel C., Marquet R., Ehresmann B., Ehresmann C. Psoralen crosslinking between human immunodeficiency virus type 1 RNA and primer tRNA3(Lys). Nucleic Acids Res. 1996 Feb 1;24(3):509–514. doi: 10.1093/nar/24.3.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Temin H. M., Mizutani S. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature. 1970 Jun 27;226(5252):1211–1213. doi: 10.1038/2261211a0. [DOI] [PubMed] [Google Scholar]
  55. Wakefield J. K., Kang S. M., Morrow C. D. Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His). J Virol. 1996 Feb;70(2):966–975. doi: 10.1128/jvi.70.2.966-975.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Wakefield J. K., Wolf A. G., Morrow C. D. Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys). J Virol. 1995 Oct;69(10):6021–6029. doi: 10.1128/jvi.69.10.6021-6029.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Westhof E., Dumas P., Moras D. Crystallographic refinement of yeast aspartic acid transfer RNA. J Mol Biol. 1985 Jul 5;184(1):119–145. doi: 10.1016/0022-2836(85)90048-8. [DOI] [PubMed] [Google Scholar]
  58. Whitcomb J. M., Ortiz-Conde B. A., Hughes S. H. Replication of avian leukosis viruses with mutations at the primer binding site: use of alternative tRNAs as primers. J Virol. 1995 Oct;69(10):6228–6238. doi: 10.1128/jvi.69.10.6228-6238.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Wöhrl B. M., Tantillo C., Arnold E., Le Grice S. F. An expanded model of replicating human immunodeficiency virus reverse transcriptase. Biochemistry. 1995 Apr 25;34(16):5343–5356. doi: 10.1021/bi00016a005. [DOI] [PubMed] [Google Scholar]
  60. Zhang Z., Kang S. M., LeBlanc A., Hajduk S. L., Morrow C. D. Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His). Virology. 1996 Dec 15;226(2):306–317. doi: 10.1006/viro.1996.0658. [DOI] [PubMed] [Google Scholar]
  61. Zhang Z., Kang S. M., Li Y., Morrow C. D. Genetic analysis of the U5-PBS of a novel HIV-1 reveals multiple interactions between the tRNA and RNA genome required for initiation of reverse transcription. RNA. 1998 Apr;4(4):394–406. [PMC free article] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES